CLDI Stock Earnings: Calidi Biotherapeutics Misses EPS for Q4 2023
![CLDI stock - CLDI Stock Earnings: Calidi Biotherapeutics Misses EPS for Q4 2023](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600-768x432.png)
Source: iQoncept / Shutterstock
Calidi Biotherapeutics (NYSEMKT:CLDI) just reported results for the fourth quarter of 2023.
- Calidi Biotherapeutics reported earnings per share of -23 cents. This was below the analyst estimate for EPS of -20 cents.
- The company did not report any revenue for the quarter.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/03/cldi-stock-earnings-calidi-biotherapeutics-for-q4-of-2023/.
©2024 InvestorPlace Media, LLC